Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion type Assertion NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_head.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion wasGeneratedBy ECO_0000203 NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_provenance.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion wasDerivedFrom befree-20140225 NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_provenance.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion SIO_000772 17018612 NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_provenance.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion evidence source_evidence_literature NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_provenance.
- NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_assertion description "[Treatment of CD9(-) parent cells with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, inhibited process outgrowth and survival, suggesting that PI3K/Akt signaling is required for the morphologic change and cell survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852602.RAjcguNKsT1vFm8ztTiLOclL37A68l8h1vQd8Bp5pn5C8130_provenance.